Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE : revenue, balance sheet and financial ratios

PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE is a French company founded 34 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CONCARNEAU (29900), this company of category PME shows in 2025 a net income positive of 25 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE (SIREN 383617313)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 25 421 € 19 053 € 42 642 € 55 204 € 43 740 € 55 343 € 51 900 € 70 361 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE generates positive net income of 25 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 70 k€ -> 25 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

25 421 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 50%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

50.0%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

56.736%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

16.1%

Solvency indicators evolution
PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE

Sector positioning

Debt ratio
50.0 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of PHARMACIE DU PASSAGE - FR... (50.00) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
56.74% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good

In 2025, the financial autonomy of PHARMACIE DU PASSAGE - FR... (56.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 90.37. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

90.372

Liquidity indicators evolution
PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE

Sector positioning

Liquidity ratio
90.37 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch

In 2025, the liquidity ratio of PHARMACIE DU PASSAGE - FR... (90.37) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE is estimated at 403 815 € (range 274 031€ - 633 642€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
274k€ 403k€ 633k€
403 815 € Range: 274 031€ - 633 642€
NAF 5 année 2025

Valuation method used

Net Income Multiple
25 421 € × 15.9x = 403 816 €
Range: 274 031€ - 633 642€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE with other companies in the same sector:

Frequently asked questions about PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE

What is the revenue of PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE ?

The revenue of PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE profitable?

Yes, PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE generated a net profit of 25 k€ in 2025.

Where is the headquarters of PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE ?

The headquarters of PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE is located in CONCARNEAU (29900), in the department Finistere.

Where to find the tax return of PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE ?

The tax return of PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE operate?

PHARMACIE DU PASSAGE - FRANCOISE RICHARD QUENEHERVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.